Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)
Purpose We performed a survey on acute heart failure (AHF) in nine countries in four continents. We aimed to describe characteristics and management of AHF among various countries, to compare patients with de novo AHF versus patients with a pre-existing episode of AHF, and to describe subpopulations...
Gespeichert in:
| Veröffentlicht in: | Intensive care medicine 2011-04, Vol.37 (4), p.619-626 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 626 |
|---|---|
| container_issue | 4 |
| container_start_page | 619 |
| container_title | Intensive care medicine |
| container_volume | 37 |
| creator | Follath, F. Yilmaz, M. B. Delgado, J. F. Parissis, J. T. Porcher, R. Gayat, E. Burrows, Nigel Mclean, A. Vilas-Boas, F. Mebazaa, A. |
| description | Purpose
We performed a survey on acute heart failure (AHF) in nine countries in four continents. We aimed to describe characteristics and management of AHF among various countries, to compare patients with de novo AHF versus patients with a pre-existing episode of AHF, and to describe subpopulations hospitalized in intensive care unit (ICU) versus cardiac care unit (CCU) versus ward.
Methods and results
Data from 4,953 patients with AHF were collected via questionnaire from 666 hospitals. Clinical presentation included decompensated congestive HF (38.6%), pulmonary oedema (36.7%) and cardiogenic shock (11.7%). Patients with de novo episode of AHF (36.2%) were younger, had less comorbidities and lower blood pressure despite greater left ventricular ejection fraction (LVEF) and were more often admitted to ICU.
Overall, intravenous (IV) diuretics were given in 89.7%, vasodilators in 41.1%, and inotropic agents (dobutamine, dopamine, adrenaline, noradrenaline and levosimendan) in 39% of cases. Overall hospital death rate was 12%, the majority due to cardiogenic shock (43%). More patients with de novo AHF (14.2%) than patients with a pre-existing episode of AHF (10.8%) (
p
= 0.0007) died. There was graded mortality in ICU, CCU and ward patients with mortality in ICU patients being the highest (17.8%) (
p
|
| doi_str_mv | 10.1007/s00134-010-2113-0 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_857481294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A724328325</galeid><sourcerecordid>A724328325</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-1d8f44657206c267ac9a05a49eb26b2084c0b8d2b156079ef197238466a58dd3</originalsourceid><addsrcrecordid>eNp1kl-L1DAUxYso7rj6AXyRoMgq2DVJ0z_zWAZnRxgR3HkPt-ntmKVNxiQV99ubbmddlJE8BG5-5yT35iTJS0YvGaXlR08py0RKGU05Y1lKHyULJjKeMp5Vj5MFzQRPRSH4WfLM-5tIl0XOniZnnPHJoFokv1a9NlpBTw4OPZoAQVvzgQxgYI9DLBAwLbFjUHZAT7Qh4TuSWo0ByQbBBbIG3Y8OyVVvm-hzPbqfeEtsR65DlIJryc4hhDuvd_W2_vYl3azfP0-edNB7fHHcz5Pd-tNutUm3X68-r-ptqnKah5S1VSdEkZecFooXJagl0BzEEhteNJxWQtGmannD8oKWS-zYsozNi6KAvGrb7Dy5mG0Pzv4Y0Qc5aK-w78GgHb2s8lJUjC9FJF__Q97Y0Zn4tgliZVZlWYTezNAeepTadDY4UJOlrEseR19lPI9UeoLao0EHvTXY6Vj-i788wcfV4qDVSQGbBcpZ7x128uD0AO5WMiqnn5VzNGSMhpyiIWnUvDr2NzYDtn8U91mIwNsjAD4GonNglPYPnKBMlHeD4jPn45HZo3sY1P9v_w2JVMwX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>857173833</pqid></control><display><type>article</type><title>Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Follath, F. ; Yilmaz, M. B. ; Delgado, J. F. ; Parissis, J. T. ; Porcher, R. ; Gayat, E. ; Burrows, Nigel ; Mclean, A. ; Vilas-Boas, F. ; Mebazaa, A.</creator><creatorcontrib>Follath, F. ; Yilmaz, M. B. ; Delgado, J. F. ; Parissis, J. T. ; Porcher, R. ; Gayat, E. ; Burrows, Nigel ; Mclean, A. ; Vilas-Boas, F. ; Mebazaa, A.</creatorcontrib><description>Purpose
We performed a survey on acute heart failure (AHF) in nine countries in four continents. We aimed to describe characteristics and management of AHF among various countries, to compare patients with de novo AHF versus patients with a pre-existing episode of AHF, and to describe subpopulations hospitalized in intensive care unit (ICU) versus cardiac care unit (CCU) versus ward.
Methods and results
Data from 4,953 patients with AHF were collected via questionnaire from 666 hospitals. Clinical presentation included decompensated congestive HF (38.6%), pulmonary oedema (36.7%) and cardiogenic shock (11.7%). Patients with de novo episode of AHF (36.2%) were younger, had less comorbidities and lower blood pressure despite greater left ventricular ejection fraction (LVEF) and were more often admitted to ICU.
Overall, intravenous (IV) diuretics were given in 89.7%, vasodilators in 41.1%, and inotropic agents (dobutamine, dopamine, adrenaline, noradrenaline and levosimendan) in 39% of cases. Overall hospital death rate was 12%, the majority due to cardiogenic shock (43%). More patients with de novo AHF (14.2%) than patients with a pre-existing episode of AHF (10.8%) (
p
= 0.0007) died. There was graded mortality in ICU, CCU and ward patients with mortality in ICU patients being the highest (17.8%) (
p
< 0.0001).
Conclusions
Our data demonstrated the existence of different subgroups based on de novo or pre-existing episode(s) of AHF and the site of hospitalization. Recognition of these subgroups might improve management and outcome by defining specific therapeutic requirements.</description><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s00134-010-2113-0</identifier><identifier>PMID: 21210078</identifier><identifier>CODEN: ICMED9</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Acute Disease ; Aged ; Aged, 80 and over ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Anesthesiology ; Biological and medical sciences ; Cardiology ; Cardiovascular disease ; Comorbidity ; Critical Care Medicine ; Diuretics ; Ejection fraction ; Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care ; Emergency Medicine ; Female ; France ; Heart ; Heart failure ; Heart Failure - drug therapy ; Heart Failure - epidemiology ; Heart Failure - physiopathology ; Hospital Mortality ; Hospital patients ; Hospitalization ; Hospitals ; Humans ; Intensive ; Intensive care ; Intensive care medicine ; Intensive Care Units ; Internationality ; Male ; Medical colleges ; Medical sciences ; Medicine ; Medicine & Public Health ; Middle Aged ; Missing data ; Mortality ; Original ; Outcome Assessment (Health Care) ; Pain Medicine ; Patients ; Pediatrics ; Pneumology/Respiratory System ; Prognosis ; Questionnaires ; Shock ; Surveys ; Surveys and Questionnaires ; Transplants & implants ; Vasodilators</subject><ispartof>Intensive care medicine, 2011-04, Vol.37 (4), p.619-626</ispartof><rights>Copyright jointly held by Springer and ESICM 2010</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2011 Springer</rights><rights>Copyright jointly held by Springer and ESICM 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-1d8f44657206c267ac9a05a49eb26b2084c0b8d2b156079ef197238466a58dd3</citedby><cites>FETCH-LOGICAL-c505t-1d8f44657206c267ac9a05a49eb26b2084c0b8d2b156079ef197238466a58dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00134-010-2113-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00134-010-2113-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24014794$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21210078$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Follath, F.</creatorcontrib><creatorcontrib>Yilmaz, M. B.</creatorcontrib><creatorcontrib>Delgado, J. F.</creatorcontrib><creatorcontrib>Parissis, J. T.</creatorcontrib><creatorcontrib>Porcher, R.</creatorcontrib><creatorcontrib>Gayat, E.</creatorcontrib><creatorcontrib>Burrows, Nigel</creatorcontrib><creatorcontrib>Mclean, A.</creatorcontrib><creatorcontrib>Vilas-Boas, F.</creatorcontrib><creatorcontrib>Mebazaa, A.</creatorcontrib><title>Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)</title><title>Intensive care medicine</title><addtitle>Intensive Care Med</addtitle><addtitle>Intensive Care Med</addtitle><description>Purpose
We performed a survey on acute heart failure (AHF) in nine countries in four continents. We aimed to describe characteristics and management of AHF among various countries, to compare patients with de novo AHF versus patients with a pre-existing episode of AHF, and to describe subpopulations hospitalized in intensive care unit (ICU) versus cardiac care unit (CCU) versus ward.
Methods and results
Data from 4,953 patients with AHF were collected via questionnaire from 666 hospitals. Clinical presentation included decompensated congestive HF (38.6%), pulmonary oedema (36.7%) and cardiogenic shock (11.7%). Patients with de novo episode of AHF (36.2%) were younger, had less comorbidities and lower blood pressure despite greater left ventricular ejection fraction (LVEF) and were more often admitted to ICU.
Overall, intravenous (IV) diuretics were given in 89.7%, vasodilators in 41.1%, and inotropic agents (dobutamine, dopamine, adrenaline, noradrenaline and levosimendan) in 39% of cases. Overall hospital death rate was 12%, the majority due to cardiogenic shock (43%). More patients with de novo AHF (14.2%) than patients with a pre-existing episode of AHF (10.8%) (
p
= 0.0007) died. There was graded mortality in ICU, CCU and ward patients with mortality in ICU patients being the highest (17.8%) (
p
< 0.0001).
Conclusions
Our data demonstrated the existence of different subgroups based on de novo or pre-existing episode(s) of AHF and the site of hospitalization. Recognition of these subgroups might improve management and outcome by defining specific therapeutic requirements.</description><subject>Acute Disease</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Anesthesiology</subject><subject>Biological and medical sciences</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Comorbidity</subject><subject>Critical Care Medicine</subject><subject>Diuretics</subject><subject>Ejection fraction</subject><subject>Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care</subject><subject>Emergency Medicine</subject><subject>Female</subject><subject>France</subject><subject>Heart</subject><subject>Heart failure</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - epidemiology</subject><subject>Heart Failure - physiopathology</subject><subject>Hospital Mortality</subject><subject>Hospital patients</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Intensive</subject><subject>Intensive care</subject><subject>Intensive care medicine</subject><subject>Intensive Care Units</subject><subject>Internationality</subject><subject>Male</subject><subject>Medical colleges</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Missing data</subject><subject>Mortality</subject><subject>Original</subject><subject>Outcome Assessment (Health Care)</subject><subject>Pain Medicine</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Pneumology/Respiratory System</subject><subject>Prognosis</subject><subject>Questionnaires</subject><subject>Shock</subject><subject>Surveys</subject><subject>Surveys and Questionnaires</subject><subject>Transplants & implants</subject><subject>Vasodilators</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kl-L1DAUxYso7rj6AXyRoMgq2DVJ0z_zWAZnRxgR3HkPt-ntmKVNxiQV99ubbmddlJE8BG5-5yT35iTJS0YvGaXlR08py0RKGU05Y1lKHyULJjKeMp5Vj5MFzQRPRSH4WfLM-5tIl0XOniZnnPHJoFokv1a9NlpBTw4OPZoAQVvzgQxgYI9DLBAwLbFjUHZAT7Qh4TuSWo0ByQbBBbIG3Y8OyVVvm-hzPbqfeEtsR65DlIJryc4hhDuvd_W2_vYl3azfP0-edNB7fHHcz5Pd-tNutUm3X68-r-ptqnKah5S1VSdEkZecFooXJagl0BzEEhteNJxWQtGmannD8oKWS-zYsozNi6KAvGrb7Dy5mG0Pzv4Y0Qc5aK-w78GgHb2s8lJUjC9FJF__Q97Y0Zn4tgliZVZlWYTezNAeepTadDY4UJOlrEseR19lPI9UeoLao0EHvTXY6Vj-i788wcfV4qDVSQGbBcpZ7x128uD0AO5WMiqnn5VzNGSMhpyiIWnUvDr2NzYDtn8U91mIwNsjAD4GonNglPYPnKBMlHeD4jPn45HZo3sY1P9v_w2JVMwX</recordid><startdate>20110401</startdate><enddate>20110401</enddate><creator>Follath, F.</creator><creator>Yilmaz, M. B.</creator><creator>Delgado, J. F.</creator><creator>Parissis, J. T.</creator><creator>Porcher, R.</creator><creator>Gayat, E.</creator><creator>Burrows, Nigel</creator><creator>Mclean, A.</creator><creator>Vilas-Boas, F.</creator><creator>Mebazaa, A.</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20110401</creationdate><title>Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)</title><author>Follath, F. ; Yilmaz, M. B. ; Delgado, J. F. ; Parissis, J. T. ; Porcher, R. ; Gayat, E. ; Burrows, Nigel ; Mclean, A. ; Vilas-Boas, F. ; Mebazaa, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-1d8f44657206c267ac9a05a49eb26b2084c0b8d2b156079ef197238466a58dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acute Disease</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Anesthesiology</topic><topic>Biological and medical sciences</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Comorbidity</topic><topic>Critical Care Medicine</topic><topic>Diuretics</topic><topic>Ejection fraction</topic><topic>Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care</topic><topic>Emergency Medicine</topic><topic>Female</topic><topic>France</topic><topic>Heart</topic><topic>Heart failure</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - epidemiology</topic><topic>Heart Failure - physiopathology</topic><topic>Hospital Mortality</topic><topic>Hospital patients</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Intensive</topic><topic>Intensive care</topic><topic>Intensive care medicine</topic><topic>Intensive Care Units</topic><topic>Internationality</topic><topic>Male</topic><topic>Medical colleges</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Missing data</topic><topic>Mortality</topic><topic>Original</topic><topic>Outcome Assessment (Health Care)</topic><topic>Pain Medicine</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Pneumology/Respiratory System</topic><topic>Prognosis</topic><topic>Questionnaires</topic><topic>Shock</topic><topic>Surveys</topic><topic>Surveys and Questionnaires</topic><topic>Transplants & implants</topic><topic>Vasodilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Follath, F.</creatorcontrib><creatorcontrib>Yilmaz, M. B.</creatorcontrib><creatorcontrib>Delgado, J. F.</creatorcontrib><creatorcontrib>Parissis, J. T.</creatorcontrib><creatorcontrib>Porcher, R.</creatorcontrib><creatorcontrib>Gayat, E.</creatorcontrib><creatorcontrib>Burrows, Nigel</creatorcontrib><creatorcontrib>Mclean, A.</creatorcontrib><creatorcontrib>Vilas-Boas, F.</creatorcontrib><creatorcontrib>Mebazaa, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Follath, F.</au><au>Yilmaz, M. B.</au><au>Delgado, J. F.</au><au>Parissis, J. T.</au><au>Porcher, R.</au><au>Gayat, E.</au><au>Burrows, Nigel</au><au>Mclean, A.</au><au>Vilas-Boas, F.</au><au>Mebazaa, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)</atitle><jtitle>Intensive care medicine</jtitle><stitle>Intensive Care Med</stitle><addtitle>Intensive Care Med</addtitle><date>2011-04-01</date><risdate>2011</risdate><volume>37</volume><issue>4</issue><spage>619</spage><epage>626</epage><pages>619-626</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><coden>ICMED9</coden><abstract>Purpose
We performed a survey on acute heart failure (AHF) in nine countries in four continents. We aimed to describe characteristics and management of AHF among various countries, to compare patients with de novo AHF versus patients with a pre-existing episode of AHF, and to describe subpopulations hospitalized in intensive care unit (ICU) versus cardiac care unit (CCU) versus ward.
Methods and results
Data from 4,953 patients with AHF were collected via questionnaire from 666 hospitals. Clinical presentation included decompensated congestive HF (38.6%), pulmonary oedema (36.7%) and cardiogenic shock (11.7%). Patients with de novo episode of AHF (36.2%) were younger, had less comorbidities and lower blood pressure despite greater left ventricular ejection fraction (LVEF) and were more often admitted to ICU.
Overall, intravenous (IV) diuretics were given in 89.7%, vasodilators in 41.1%, and inotropic agents (dobutamine, dopamine, adrenaline, noradrenaline and levosimendan) in 39% of cases. Overall hospital death rate was 12%, the majority due to cardiogenic shock (43%). More patients with de novo AHF (14.2%) than patients with a pre-existing episode of AHF (10.8%) (
p
= 0.0007) died. There was graded mortality in ICU, CCU and ward patients with mortality in ICU patients being the highest (17.8%) (
p
< 0.0001).
Conclusions
Our data demonstrated the existence of different subgroups based on de novo or pre-existing episode(s) of AHF and the site of hospitalization. Recognition of these subgroups might improve management and outcome by defining specific therapeutic requirements.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>21210078</pmid><doi>10.1007/s00134-010-2113-0</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0342-4642 |
| ispartof | Intensive care medicine, 2011-04, Vol.37 (4), p.619-626 |
| issn | 0342-4642 1432-1238 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_857481294 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Acute Disease Aged Aged, 80 and over Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anesthesiology Biological and medical sciences Cardiology Cardiovascular disease Comorbidity Critical Care Medicine Diuretics Ejection fraction Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care Emergency Medicine Female France Heart Heart failure Heart Failure - drug therapy Heart Failure - epidemiology Heart Failure - physiopathology Hospital Mortality Hospital patients Hospitalization Hospitals Humans Intensive Intensive care Intensive care medicine Intensive Care Units Internationality Male Medical colleges Medical sciences Medicine Medicine & Public Health Middle Aged Missing data Mortality Original Outcome Assessment (Health Care) Pain Medicine Patients Pediatrics Pneumology/Respiratory System Prognosis Questionnaires Shock Surveys Surveys and Questionnaires Transplants & implants Vasodilators |
| title | Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A59%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20presentation,%20management%20and%20outcomes%20in%20the%20Acute%20Heart%20Failure%20Global%20Survey%20of%20Standard%20Treatment%20(ALARM-HF)&rft.jtitle=Intensive%20care%20medicine&rft.au=Follath,%20F.&rft.date=2011-04-01&rft.volume=37&rft.issue=4&rft.spage=619&rft.epage=626&rft.pages=619-626&rft.issn=0342-4642&rft.eissn=1432-1238&rft.coden=ICMED9&rft_id=info:doi/10.1007/s00134-010-2113-0&rft_dat=%3Cgale_proqu%3EA724328325%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=857173833&rft_id=info:pmid/21210078&rft_galeid=A724328325&rfr_iscdi=true |